Tomas Kiselak

Managing Member, Fairmount

Mr. Kiselak is a Managing Member at Fairmount, a healthcare investment firm he co-founded in April 2016. Prior to Fairmount, Mr. Kiselak was a managing director at RA Capital Management, LLC. Mr. Kiselak serves as chairman of the board of directors of Viridian Therapeutics and is a director for Apogee Therapeutics, Dianthus Therapeutics, Spyre Therapeutics, Zenas BioPharma, and several private companies. He received his Bachelors in Neuroscience and Economics from Amherst College.